First Nasal Spray For Treating Adult Covid Patients Launched In India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.

Related Keywords

Mumbai ,Maharashtra ,India ,Robert Crockart ,Monika Tandon ,Srikanth Krishnamurthy ,Utah State University United States ,Glenmark Pharmaceuticals Ltd ,Nitric Oxide Nasal Spray ,Drugs Controller General ,Oxide Nasal Spray ,Nitric Oxide Nasal ,Chief Commercial Officer Robert Crockart ,Clinical Development ,Glenmark Pharmaceuticals ,Principal Investigators ,Covid Nasal Spray ,Fabispray ,Glenmark ,